S. Mazzotta

发表

Modified BEAM as conditioning regimen for lymphoma patients undergoing autologous hematopoietic stem cell transplantation

P. Galieni, V. Pezzoni, C. Bigazzi, 2018, Bone Marrow Transplantation.

A novel t(6;7)(p24;q21) in a chronic myelocytic leukemia in complete cytogenetic remission after therapy with imatinib mesylate.

F. Lauria, A. Gozzetti, D. Raspadori, 2004, Cancer genetics and cytogenetics.

PEG Intron Treatment in 90 Patients with Essential Thrombocythemia (ET) Final Report of a Phase II Study.

M. Gobbi, R. Fanin, P. Mazza, 2005 .

A case of adult acute myelocytic leukemia (M5a) with a near-tetraploid karyotype characterized by monosomies 5 and 16.

M. Pirrotta, A. Bucalossi, F. Lauria, 2004, Cancer Genetics and Cytogenetics.

Disseminated Mucormycosis in a Patient with Acute Myeloblastic Leukemia Misdiagnosed as Infection by Enterococcus faecium

A. Bucalossi, F. Lauria, M. Tozzi, 2004, Journal of Clinical Microbiology.

Pancreatitis caused by measles, mumps, and rubella vaccine.

J. Barkin, S. Mazzotta, J. Adler, 1991, Pancreas.

Circulating plasma cells in newly diagnosed symptomatic multiple myeloma as a possible prognostic marker for patients with standard‐risk cytogenetics

P. Galieni, A. Natale, V. Pezzoni, 2015, British journal of haematology.

Low-dose thalidomide-induced agranulocytosis in a multiple myeloma patient treated at diagnosis

M. Pirrotta, A. Bucalossi, F. Lauria, 2005, Leukemia & lymphoma.

Thrombotic thrombocytopenic purpura secondary to an occult adenocarcinoma.

M. Pirrotta, F. Forconi, A. Bucalossi, 2005, The oncologist.

The detection of circulating plasma cells may improve the Revised International Staging System (R‐ISS) risk stratification of patients with newly diagnosed multiple myeloma

P. Galieni, P. Picardi, V. Pezzoni, 2021, British journal of haematology.

Increased serum lactate dehydrogenase isoenzymes in Ph-negative chronic myeloproliferative diseases: A metabolic adaptation?

S. Petralia, R. Guerranti, A. Bucalossi, 2006, Hematology.

Is an Antiemetic Prophylactic Treatment Needed for Patients Submitted to Consecutive Days of 5-fluorouracil? An Observational Study

A. Favero, M. Maltoni, D. Amadori, 2001, Tumori.

Massive intravascular hemolysis: a fatal complication of Clostridium perfringens septicemia in a patient with acute lymphoblastic leukemia

M. Pirrotta, F. Forconi, A. Bucalossi, 2005, Leukemia & lymphoma.

Circulating plasma cells in newly diagnosed symptomatic multiple myeloma as a possible prognostic marker for patients with standard‐risk cytogenetics

P. Galieni, A. Natale, C. Bigazzi, 2015, British journal of haematology.

Management of vulnerable patient phenotypes and acute coronary syndrome mechanisms

G. Scalone, P. Grossi, S. Silenzi, 2024, International Journal of Cardiology.

Unmutated IGHV at diagnosis in patients with early stage CLL independently predicts for shorter follow-up time to first treatment (TTFT).

C. Bigazzi, S. Mazzotta, M. Ruggieri, 2024, Leukemia research.